Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response

Fig. 3

Response of orthotopic B4B8 murine HNSCC tumors to AZD8931. B4B8 cells were inoculated into the buccal space of BALB/c mice as described in the Materials and Methods. When tumors reached 40 to 50 mm3 (~ 15 to 16 days after inoculation), mice were randomized for daily gavage with diluent or 50 m/kg AZD8931. Tumor diameter was measured with calipers and volume was calculated as described. a Time course of growth of buccal B4B8 tumors treated daily by oral gavage with diluent control (n = 50) or 50 mg/kg AZD8931 (n = 53). The data are the mean and SEM of three independent compiled experiments. b The therapeutic responses of individual B4B8 tumors after 7 days of diluent or AZD8931 treatment are presented as the percent change from initial tumor volume

Back to article page